Brillient JV wins FDA Oncology Center For Excellence (OCE) support contract

This 8(a) joint venture, which includes an award-winning Full Spectrum Digital Transformation company and 2024 Elev8 GovCon Honoree, was awarded a contract to support the Center which unites experts across the FDA to conduct expedited review of medical products for oncologic and hematologic malignancies.

Awardee Name: ANEON BRILLIENT, LLC
Unique Entity ID: MS8HMAY331Q5
Total Contract Value: $2,114,246.96
Action Obligation: $2,114,246.96
Department Name: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Funding Agency: FOOD AND DRUG ADMINISTRATION
Funding Office: FDA OFFICE OF ACQ GRANT SVCS
Number of Bidders: 1
Award ID: 75F40124C00068
RFP ID: 75F40124R00079
Set Aside Used: 8(a) Sole Source

More here.

🔊 Listen to Story